Scisparc Stock Investor Sentiment

SPRC Stock  USD 0.21  0.01  4.55%   
About 61% of Scisparc's investor base is looking to short. The analysis of the overall investor sentiment regarding Scisparc suggests that many traders are alarmed. The current market sentiment, together with Scisparc's historical and current headlines, can help investors time the market. In addition, many technical investors use Scisparc stock news signals to limit their universe of possible portfolio assets.
  

Scisparc Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Scisparc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three weeks ago at news.google.com         
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
SciSparc Ltd. Short Interest Down 56.3 percent in October
news
over a month ago at thelincolnianonline.com         
SciSparc Ltd. Short Interest Update
news
over a month ago at finance.yahoo.com         
National Poll on Perceptions of Mental Health and Suicide Prevention Reveals Most U.S. Adults Believ...
Yahoo News
over a month ago at benzinga.com         
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
benzinga news
over a month ago at finance.yahoo.com         
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrou...
Yahoo News
over two months ago at thelincolnianonline.com         
Short Interest in SciSparc Ltd. Rises By 691.3
news
over two months ago at news.google.com         
SciSparc Ltd. Proposes Reverse Stock Split - TipRanks
Google News at Macroaxis
over two months ago at finance.yahoo.com         
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
Yahoo News
over two months ago at seekingalpha.com         
SciSparc signs LOI to sell entire ownership in MitoCareX
seekingalpha News
over two months ago at finance.yahoo.com         
SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment
Yahoo News
over two months ago at globenewswire.com         
SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical T...
Macroaxis News: globenewswire.com
over two months ago at globenewswire.com         
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Appli...
Macroaxis News: globenewswire.com
over two months ago at finance.yahoo.com         
SciSparc Advances 1.85 million Loan to AutoMax, Following AutoMaxs Direct Import Agreement with Majo...
Yahoo News
over two months ago at seekingalpha.com         
SciSparc extends additional loan of 1.85M to AutoMax
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Scisparc that are available to investors today. That information is available publicly through Scisparc media outlets and privately through word of mouth or via Scisparc internal channels. However, regardless of the origin, that massive amount of Scisparc data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Scisparc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Scisparc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Scisparc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Scisparc alpha.

Scisparc Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
SciSparc extends additional loan of 1.85M to AutoMax
09/11/2024
2
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy
09/16/2024
3
SciSparc signs LOI to sell entire ownership in MitoCareX
09/26/2024
4
National Poll on Perceptions of Mental Health and Suicide Prevention Reveals Most U.S. Adults Believe Suicide is Preventable
10/09/2024
5
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
11/04/2024

Complementary Tools for Scisparc Stock analysis

When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format